Assenagon Asset Management S.A. Adma Biologics, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 12,050 shares of ADMA stock, worth $215,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,050

Previous 399,922 96.99%

Holding current value

$215,454

Previous $7.93 Million 97.24%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$17.6 - $24.51 $6.83 Million - $9.51 Million	-387,872 Reduced 96.99%	12,050 $219,000
Q1 2025 Apr 15, 2025	SELL	$15.44 - $20.61 $2.96 Million - $3.95 Million	-191,757 Reduced 32.41%	399,922 $7.93 Million
Q4 2024 Jan 14, 2025	SELL	$15.62 - $22.62 $45 Million - $65.2 Million	-2,882,776 Reduced 82.97%	591,679 $10.1 Million
Q3 2024 Oct 23, 2024	BUY	$11.21 - $20.03 $1.03 Million - $1.85 Million	92,281 Added 2.73%	3,474,455 $69.5 Million
Q2 2024 Jul 18, 2024	BUY	$5.98 - $11.18 $213,527 - $399,204	35,707 Added 1.07%	3,382,174 $37.8 Million
Q1 2024 Apr 24, 2024	SELL	$4.4 - $6.74 $2.63 Million - $4.04 Million	-598,758 Reduced 15.18%	3,346,467 $22.1 Million
Q4 2023 Jan 17, 2024	SELL	$3.08 - $4.52 $3.35 Million - $4.92 Million	-1,088,946 Reduced 21.63%	3,945,225 $17.8 Million
Q3 2023 Nov 06, 2023	SELL	$3.47 - $4.61 $2.1 Million - $2.79 Million	-605,799 Reduced 10.74%	5,034,171 $18 Million
Q2 2023 Jul 25, 2023	SELL	$3.12 - $4.22 $3.2 Million - $4.33 Million	-1,025,051 Reduced 15.38%	5,639,970 $20.8 Million
Q1 2023 Apr 18, 2023	BUY	$3.01 - $3.87 $12.9 Million - $16.6 Million	4,299,301 Added 181.73%	6,665,021 $22.1 Million
Q4 2022 Jan 12, 2023	BUY	$2.47 - $3.88 $3.21 Million - $5.04 Million	1,297,973 Added 121.56%	2,365,720 $9.18 Million
Q3 2022 Oct 27, 2022	SELL	$2.03 - $2.86 $43,360 - $61,089	-21,360 Reduced 1.96%	1,067,747 $2.6 Million
Q2 2022 Jul 27, 2022	BUY	$1.43 - $2.2 $837,561 - $1.29 Million	585,707 Added 116.35%	1,089,107 $2.16 Million
Q1 2022 Apr 25, 2022	BUY	$1.28 - $1.83 $476,103 - $680,679	371,956 Added 282.98%	503,400 $921,000
Q4 2021 Feb 01, 2022	BUY	$1.09 - $1.66 $54,389 - $82,832	49,899 Added 61.19%	131,444 $185,000
Q3 2021 Oct 19, 2021	BUY	$1.13 - $1.65 $21,660 - $31,628	19,169 Added 30.73%	81,545 $92,000
Q2 2021 Jul 15, 2021	SELL	$1.51 - $2.07 $22,364 - $30,658	-14,811 Reduced 19.19%	62,376 $100,000
Q1 2021 Apr 26, 2021	BUY	$1.67 - $2.95 $128,902 - $227,701	77,187 New	77,187 $136,000
Q3 2020 Oct 07, 2020	SELL	$2.04 - $3.74 $841,569 - $1.54 Million	-412,534 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$2.42 - $3.29 $998,332 - $1.36 Million	412,534 New	412,534 $1.21 Million

Others Institutions Holding ADMA

# of Institutions

382

Shares Held

187M

Call Options Held

2.53M

Put Options Held

696K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.51B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Adma Biologics, Inc. Transaction History